ICANS

Clinical trials for ICANS explained in plain language.

Never miss a new study

Get alerted when new ICANS trials appear

Sign up with your email to follow new studies for ICANS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

Old drug tested to tame dangerous side effects of Cutting-Edge cancer treatments

Disease control Recruiting now

This early-stage study is testing if an existing drug called methylene blue can help control severe side effects that sometimes occur after powerful cancer immunotherapies like CAR-T. The side effects, called CRS and ICANS, involve dangerous immune system overreactions and neurol…

Matched conditions: ICANS

Phase: PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control

Last updated Mar 25, 2026 14:07 UTC

ICANS

Get alerted when new ICANS trials appear

Old drug tested to tame dangerous side effects of Cutting-Edge cancer treatments